Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Robert S Epstein"'
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0261336 (2022)
Subcutaneous (SC) administration of rituximab provides an opportunity for reduced patient treatment burden and increased healthcare efficiencies as an alternative to intravenous (IV) rituximab. There is minimal evidence comparing costs associated wit
Externí odkaz:
https://doaj.org/article/bc497e8f54934627933fa49233d92b93
Autor:
Deborah T Gold, Richard Weiss, Tammy Beckett, Chad Deal, Robert S Epstein, Andrew L James, Jacqueline M Kernaghan, Mahshid Mohseni, Michael Spiegel, Tamara Vokes, Jenna Roberts, Tom Bailey, Yamei Wang, Setareh A Williams
Publikováno v:
JBMR Plus, Vol 5, Iss 3, Pp n/a-n/a (2021)
ABSTRACT Despite the availability of various osteoporosis treatments, adherence remains suboptimal. One contributing factor may be patient experience with therapy. This US, multicenter, combined retrospective chart review and patient questionnaire st
Externí odkaz:
https://doaj.org/article/06691ad000494ce196277b22c4706f51
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Background: Hypomethylating agents (HMAs) are guideline-recommended treatment for higher-risk myelodysplastic syndromes/neoplasms (MDS). However, a prior survey of patients with MDS reported challenges with intravenous (IV) and subcutaneous (SC) HMA
Externí odkaz:
https://doaj.org/article/242ae770e431480485a506cd2325b6d7
Publikováno v:
Cancer Treatment and Research Communications, Vol 31, Iss , Pp 100555- (2022)
Purpose: To depict the treatment journey for patients with small cell lung cancer (SCLC) and evaluate health care resource utilization (HCRU) associated with myelosuppression, a complication induced by chemotherapy or chemotherapy plus radiation ther
Externí odkaz:
https://doaj.org/article/4ee3d2cfc55845418b6f73624ff906ea
Autor:
Tong J. Gan, Robert S. Epstein, Megan L. Leone-Perkins, Tehseen Salimi, Sheikh Usman Iqbal, Peter G. Whang
Publikováno v:
Pain and Therapy, Vol 7, Iss 2, Pp 205-216 (2018)
Abstract Introduction The management of acute postoperative pain remains a significant challenge for physicians. Poorly controlled postoperative pain is associated with poorer overall outcomes. Methods Between April and May 2017, physicians from an o
Externí odkaz:
https://doaj.org/article/0149bbb318b943ef8b732cc2ba23e89c
Autor:
Amer M. Zeidan, Namita Joshi, Hrishikesh Kale, Wei-Jhih Wang, Shelby Corman, Tehseen Salimi, Robert S. Epstein
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:670-679
Previous analyses using the SEER-Medicare database have reported substantial underutilization of hypomethylating agents (HMAs) among patients with higher-risk myelodysplastic syndromes (MDS), and an association between poor HMA persistence and high e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0385d789603c375d048eeab05abd5a6d
https://doi.org/10.1016/j.clml.2022.04.016
https://doi.org/10.1016/j.clml.2022.04.016
Autor:
Amer M. Zeidan, Victoria Divino, Mitch DeKoven, Elizabeth Wang, Justin Chen, Tehseen Salimi, Robert S. Epstein
Publikováno v:
Blood. 140:4047-4049
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73ca126c9d6f75c4120e6d3a7dd638c1
https://doi.org/10.1182/blood-2022-157926
https://doi.org/10.1182/blood-2022-157926
Autor:
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, Juan W. Valle, Chigusa Morizane, Thomas B. Karasic, Thomas A. Abrams, Junji Furuse, Robin K. Kelley, Philippe A. Cassier, Heinz-Josef Klümpen, Heung-Moon Chang, Li-Tzong Chen, Josep Tabernero, Do-Youn Oh, Amit Mahipal, Markus Moehler, Edith P. Mitchell, Yoshito Komatsu, Kunihiro Masuda, Daniel Ahn, Robert S. Epstein, Abdel-Baset Halim, Yao Fu, Tehseen Salimi, Volker Wacheck, Yaohua He, Mei Liu, Karim A. Benhadji, John A. Bridgewater
Publikováno v:
New England Journal of Medicine, 388(3), 228-239. Massachussetts Medical Society
Goyal, L, Meric-Bernstam, F, Hollebecque, A, Valle, J W, Morizane, C, Karasic, T B, Abrams, T A, Furuse, J, Kelley, R K, Cassier, P A, Klümpen, H-J, Chang, H-M, Chen, L-T, Tabernero, J, Oh, D-Y, Mahipal, A, Moehler, M, Mitchell, E P, Komatsu, Y, Masuda, K, Ahn, D, Epstein, R S, Halim, A-B, Fu, Y, Salimi, T, Wacheck, V, He, Y, Liu, M, Benhadji, K A & Bridgewater, J A 2023, ' Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma ', New England Journal of Medicine, vol. 388, no. 3, pp. 228-239 . https://doi.org/10.1056/NEJMoa2206834
Goyal, L, Meric-Bernstam, F, Hollebecque, A, Valle, J W, Morizane, C, Karasic, T B, Abrams, T A, Furuse, J, Kelley, R K, Cassier, P A, Klümpen, H-J, Chang, H-M, Chen, L-T, Tabernero, J, Oh, D-Y, Mahipal, A, Moehler, M, Mitchell, E P, Komatsu, Y, Masuda, K, Ahn, D, Epstein, R S, Halim, A-B, Fu, Y, Salimi, T, Wacheck, V, He, Y, Liu, M, Benhadji, K A & Bridgewater, J A 2023, ' Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma ', New England Journal of Medicine, vol. 388, no. 3, pp. 228-239 . https://doi.org/10.1056/NEJMoa2206834
Background: Alterations in fibroblast growth factor receptor 2 (FGFR2) have emerged as promising drug targets for intrahepatic cholangiocarcinoma, a rare cancer with a poor prognosis. Futibatinib, a next-generation, covalently binding FGFR1-4 inhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0afcafd318735846a74b18ed60752c0b
https://research.vumc.nl/en/publications/cd4cc245-ebdb-4ee6-adae-ae845072be13
https://research.vumc.nl/en/publications/cd4cc245-ebdb-4ee6-adae-ae845072be13
Autor:
Robert S. Epstein, Roshanthi K. Weerasinghe, Amy S. Parrish, JoAnn Krenitsky, Rachel E. Sanborn, Tehseen Salimi
Publikováno v:
Journal of medical economics. 25(1)
Chemotherapy-induced myelosuppression, which commonly exhibits as neutropenia, anemia, or thrombocytopenia, represents a substantial burden for patients with cancer that affects health-related quality of life and increases healthcare resource utiliza
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b8fc2cb4f151bfc519ac354897d305c
https://pubmed.ncbi.nlm.nih.gov/34927520
https://pubmed.ncbi.nlm.nih.gov/34927520
Autor:
Justin R. Ortiz, Laurie Kamimoto, Ronald E. Aubert, Jianying Yao, David K. Shay, Joseph S. Bresee, Robert S. Epstein
Publikováno v:
Emerging Infectious Diseases, Vol 14, Iss 8, Pp 1280-1283 (2008)
We reviewed information from a US pharmacy benefits manager database from 2004 through 2005 during periods with little influenza activity. We calculated rates of oseltamivir prescriptions to enrollees. Prescription rates increased significantly from
Externí odkaz:
https://doaj.org/article/6fb04e3379284c0593526d5e7832a18c